Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

被引:32
|
作者
Tramper-Stranders, G. A. [1 ]
van der Ent, C. K. [1 ]
Molin, S. [2 ]
Yang, L. [2 ]
Hansen, S. K. [2 ]
Rau, M. H. [2 ]
Ciofu, O. [3 ]
Johansen, H. K. [4 ,5 ]
Wolfs, T. F. W. [6 ]
机构
[1] Wilhelmina Childrens Hosp, Cyst Fibrosis Ctr, Univ Med Ctr Utrecht, Dept Paediat Resp Med, NL-3508 AB Utrecht, Netherlands
[2] Tech Univ Denmark, Infect Microbiol Grp, Ctr Syst Biol, DK-2800 Lyngby, Denmark
[3] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Danish CF Ctr, DK-2100 Copenhagen, Denmark
[6] Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands
关键词
Chronic infection; cystic fibrosis; genotyping; Pseudomonas aeruginosa; virulence; III SECRETION; PULMONARY INFECTIONS; GENETIC ADAPTATION; DCTA GENE; COLONIZATION; VIRULENCE; STRAINS; MICROEVOLUTION; INACTIVATION; PATHOGEN;
D O I
10.1111/j.1469-0691.2011.03627.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2012; 18: 567574 Abstract Despite intensive eradication therapy, some CF patients with early Pseudomonas aeruginosa infection rapidly develop a chronic infection. To elucidate factors associated with this persistence, bacterial characteristics of early P. aeruginosa isolates were analysed that were either eradicated rapidly or persisted despite multiple antimicrobial treatments. Eighty-six early infection episodes were studied. First P. aeruginosa isolates from patients with eradication (36) or persistent infection (16) were included; isolates from patients with intermittent infection (34) were omitted from the study. Virulence assays, antimicrobial resistance, cytotoxicity and mutation frequencies were analysed in vitro. P. aeruginosa was genotyped by SNP-array. Transcriptomic profiles of two eradicated and two persistent strains were compared. Nineteen per cent of patients developed persistent infection; 42% achieved eradication. Secretion of virulence factors and mutation frequencies were highly variable among both eradicated and persistent isolates and were not different between the groups. Cytotoxicity was present in 57% of eradicated vs. 100% of persistent isolates (p <0.01). None of the isolates were resistant to antibiotics. The isolates were genotypically highly diverse. Multivariate analysis showed that in vitro determined bacterial characteristics could not predict persistence after first P. aeruginosa infection. Preliminary transcriptomic data showed increased expression of some genes related to a metabolic pathway. The early onset of chronic infection was not associated with (in vitro determined) bacterial characteristics only. Although the persistent isolates were more often cytotoxic, for the individual patient it was not possible to predict the risk of persistence based on bacterial characteristics. Unknown factors such as host-pathogen and pathogen-pathogen interactions should be further explored.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [21] Metabolic flux analyses of Pseudomonas aeruginosa cystic fibrosis isolates
    Opperman, Michael J.
    Shachar-Hill, Yair
    METABOLIC ENGINEERING, 2016, 38 : 251 - 263
  • [22] Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections
    Davis, Trenton J.
    Karanjia, Ava, V
    Bhebhe, Charity N.
    West, Sarah B.
    Richardson, Matthew
    Bean, Heather D.
    MSPHERE, 2020, 5 (05):
  • [23] Occurrence of Pseudomonas aeruginosa in waters: implications for patients with cystic fibrosis (CF)
    Caskey, S.
    Stirling, J.
    Moore, J. E.
    Rendall, J. C.
    LETTERS IN APPLIED MICROBIOLOGY, 2018, 66 (06) : 537 - 541
  • [24] Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis
    Zemanick, Edith T.
    Bell, Scott C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (06) : 636 - 645
  • [25] Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an Ex Vivo Pig Model of the Cystic Fibrosis Lung
    Harrington, Niamh E.
    Littler, Jenny L.
    Harrison, Freya
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2022, 88 (03)
  • [26] Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
    Okur, Dicle Sener
    Yuruyen, Caner
    Gungor, Ozge
    Aktas, Zerrin
    Erturan, Zayre
    Akcakaya, Necla
    Camcioglu, Yildiz
    Cokugras, Haluk
    Koksalan, Kaya
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 675 - 685
  • [27] Essential Oils Biofilm Modulation Activity and Machine Learning Analysis on Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Artini, Marco
    Papa, Rosanna
    Sapienza, Filippo
    Bozovic, Mijat
    Vrenna, Gianluca
    Assanti, Vanessa Tuccio Guarna
    Sabatino, Manuela
    Garzoli, Stefania
    Fiscarelli, Ersilia Vita
    Ragno, Rino
    Selan, Laura
    MICROORGANISMS, 2022, 10 (05)
  • [28] In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients
    VanDevanter, Donald R.
    Van Dalfsen, Jill M.
    Burns, Jane L.
    Mayer-Hamblett, Nicole
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (02) : 151 - 154
  • [29] Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Ratjen, Felix
    CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (06) : 428 - 432
  • [30] EVALUATION OF BIOFILM PRODUCTION BY PSEUDOMONAS AERUGINOSA ISOLATES RECOVERED FROM CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS PATIENTS
    Perez, L. R. R.
    Costa, M. C. N.
    Freitas, A. L. P.
    Barth, A. L.
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2011, 42 (02) : 476 - 479